“Abnormal Expression of WSB1 in Lung Adenocarcinoma: A Potential Prognostic and Immunotherapeutic Sensitivity Biomarker”. 2025. Advances in World Medical Research 1 (2): 48-63. https://doi.org/10.71204/1bcv8650.